The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

Page 72 of 100

CTAD 2017 Statistical workshop: Estimands and primary analyses in AD clinical trials

The primary objective of a clinical trial should be clearly defined with regard to the target of estimation (estimand) for the efficacy of an investigational drug. The fully specified treatment effect of interest should then determine the data collection, data… Continue Reading →

CTAD 10th Conference on Clinical Trials in Alzheimer’s Disease

Abstracts are available. Astracts CTAD 2017  

Clinical evaluation of 18F-PI-2620, a next generation tau pet agent in subjects with alzheimer’s disease and progressive supranuclear palsy

Intracellular tau deposition is a key pathologic feature of alzheimer’s disease (AD) and other neurodegenerative disorders. Several positron emission tomography tau probes have been developed for in vivo detection of brain tau load, although quantification is challenging due to high… Continue Reading →

« Older posts Newer posts »

© 2025 Aging-news